Comparison of epoetin alfa and darbepoetin alfa doses routinely used in clinical practice in Department of Defense beneficiaries

被引：0
|
作者：
Cota, J. M.
Bretzke, D. R.
Allerman, A. A.
Meade, D. J.
Trice, S.
机构：
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
[2] Dept Defense Pharmaecon Ctr, Houston, TX USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)69007-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A154 / A154
页数：1
相关论文
共 50 条
  • [31] A COMPARISON OF IV EPOETIN-ALFA (EPREX) AND DARBEPOETIN-ALFA (ARANESP) IN HAEMODIALYSIS PATIENTS IN THE PILBARA DIALYSIS UNIT
    Irish, A.
    Cochrane, R.
    NEPHROLOGY, 2007, 12 : A20 - A20
  • [32] Comparison of epoetin alfa (EPO) and darbepoetin alfa (DARB) utilization in cancer chemotherapy patients treated in a hospital outpatient setting
    Vekeman, F.
    LaFeuille, M.
    Bailey, R.
    Piech, C. Tak
    McKenzie, R. S.
    Lefebvre, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA OUTPATIENTS
    Lafeuille, M. H.
    Bailey, R. A.
    Senbetta, M.
    McKenzie, R. S.
    Lefebvre, P.
    VALUE IN HEALTH, 2011, 14 (03) : A160 - A160
  • [34] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN A CHRONIC KIDNEY DISEASE POPULATION TREATED IN THE HOSPITAL OUTPATIENT SETTING
    Vekeman, Francis
    McKenzie, R. Scott
    Lafeuille, Marie-Helene
    Bailey, Robert A.
    Piech, Catherine Tak
    Lefebvre, Patrick
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A78 - A78
  • [35] DOSING PATTERN AND COST COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA INPATIENTS
    Lafeuille, M. H.
    Bailey, R. A.
    Senbetta, M.
    McKenzie, R. S.
    Lefebvre, P.
    VALUE IN HEALTH, 2011, 14 (03) : A161 - A161
  • [36] Comparison of hemoglobin response in hospitalized hemodialysis patients receiving either epoetin alfa or darbepoetin alfa in an integrated health care system
    Lew, I
    Adamson, R
    PHARMACOTHERAPY, 2004, 24 (10): : 1446 - 1447
  • [37] Evolving uses of Epoetin alfa and cladribine in clinical practice - Preface
    Tallman, MS
    SEMINARS IN HEMATOLOGY, 1996, 33 (01) : 1 - 1
  • [38] A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia
    Steensma, David P.
    Dakhil, Shaker R.
    Novotny, Paul J.
    Sloan, Jeff A.
    Johnson, David B.
    Anderson, Daniel M.
    Mattar, Bassam I.
    Moore, Dennis F., Jr.
    Nikcevich, Daniel
    Loprinzi, Charles L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (10) : 877 - 881
  • [39] A Randomized Comparison of Standard Weekly Epoetin Alfa to Every-3-Week Epoetin Alfa and Every-3-Week Darbepoetin Alfa: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC)
    Steensma, David P.
    Dakhil, Shaker R.
    Novotny, Paul J.
    Sloan, Jeff A.
    Johnson, David B.
    Anderson, Daniel. M.
    Mattar, Bassani I.
    Moore, Dennis F., Jr.
    Nikcevich, Daniel
    Loprinzi, Charles L.
    BLOOD, 2009, 114 (22) : 1172 - 1172
  • [40] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN A CHRONIC KIDNEY DISEASE POPULATION TREATED IN THE HOSPITAL INPATIENT AND OUTPATIENT SETTING
    Lafeuille, Marie-Helene
    Bailey, Robert A.
    Senbetta, Mekre
    Lefebvre, Patrick
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A56 - A56
12345